Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

The relationship of NT-proBNP and dialysis parameters with outcome of incident haemodialysis patients: results from the membrane permeability outcome study.

Locatelli F, Hannedouche T, Martin-Malo A, Jacobson SH, Vanholder R, Ronco C, La Milia V, Lopez Gomez JM, Stefoni S, Maheut H, Klinger M, Krummel T, Dhondt A, Berdud I, Gauly A.

Blood Purif. 2013;35(1-3):216-23. doi: 10.1159/000347076. Epub 2013 Mar 28.

PMID:
23548674
2.

Comparison of B-type natriuretic peptide and NT proBNP as predictors of survival in patients on high-flux hemodialysis and hemodiafiltration.

Sivalingam M, Suresh M, Farrington K.

Hemodial Int. 2011 Jul;15(3):359-65. doi: 10.1111/j.1542-4758.2011.00557.x. Epub 2011 May 31.

PMID:
21624043
3.

N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency.

Harbaum L, Hennigs JK, Baumann HJ, Lüneburg N, Griesch E, Bokemeyer C, Grünig E, Klose H.

PLoS One. 2014 Apr 21;9(4):e94263. doi: 10.1371/journal.pone.0094263. eCollection 2014.

4.

Cardiac biomarkers are influenced by dialysis characteristics.

Sommerer C, Heckele S, Schwenger V, Katus HA, Giannitsis E, Zeier M.

Clin Nephrol. 2007 Dec;68(6):392-400.

PMID:
18184522
5.

N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.

Ndrepepa G, Kastrati A, Braun S, Mehilli J, Niemöller K, von Beckerath N, von Beckerath O, Vogt W, Schömig A.

Am J Med. 2006 Apr;119(4):355.e1-8.

PMID:
16564781
6.

Admission NT-proBNP levels, renal insufficiency and age as predictors of mortality in elderly patients hospitalized for acute dyspnea.

Reny JL, Millot O, Vanderecamer T, Vergnes C, Barazer I, Sedighian S, Berdagué P.

Eur J Intern Med. 2009 Jan;20(1):14-9. doi: 10.1016/j.ejim.2008.03.006. Epub 2008 Apr 29.

PMID:
19237086
7.

Prediction of clinical outcome in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) using the TIMI risk score extended by N-terminal pro-brain natriuretic peptide levels.

Jarai R, Iordanova N, Jarai R, Jarai F, Raffetseder A, Woloszczuk W, Gyöngyösi M, Geyer G, Wojta J, Huber K.

Wien Klin Wochenschr. 2007;119(21-22):626-32.

PMID:
18043882
8.

Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.

Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL Jr.

J Am Coll Cardiol. 2006 Jan 3;47(1):91-7. Epub 2005 Dec 9.

9.

Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.

van Hateren KJ, Alkhalaf A, Kleefstra N, Groenier KH, de Jong PE, de Zeeuw D, Gans RO, Struck J, Bilo HJ, Gansevoort RT, Bakker SJ.

Clin Chem. 2012 Jan;58(1):293-7. doi: 10.1373/clinchem.2011.166348. Epub 2011 Sep 26.

10.

Cardiac biomarkers and survival in haemodialysis patients.

Sommerer C, Beimler J, Schwenger V, Heckele N, Katus HA, Giannitsis E, Zeier M.

Eur J Clin Invest. 2007 May;37(5):350-6.

PMID:
17461980
11.

N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.

Guo Q, Bárány P, Qureshi AR, Snaedal S, Heimburger O, Stenvinkel P, Lindholm B, Axelsson J.

Am J Nephrol. 2009;29(6):516-23. doi: 10.1159/000185628. Epub 2008 Dec 12.

PMID:
19077418
12.

N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension.

Leuchte HH, El Nounou M, Tuerpe JC, Hartmann B, Baumgartner RA, Vogeser M, Muehling O, Behr J.

Chest. 2007 Feb;131(2):402-9.

PMID:
17296640
13.

N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.

Madsen LH, Ladefoged S, Corell P, Schou M, Hildebrandt PR, Atar D.

Kidney Int. 2007 Mar;71(6):548-54. Epub 2007 Feb 14.

PMID:
17299526
14.

N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART.

Berg T, Zdunek D, Stalke J, Dupke S, Baumgarten A, Carganico A, Hess G.

Eur J Med Res. 2007 Apr 26;12(4):152-60.

PMID:
17509959
15.

Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.

Racek J, Králová H, Trefil L, Rajdl D, Eiselt J.

Nephron Clin Pract. 2006;103(4):c162-72. Epub 2006 Apr 25.

PMID:
16645318
16.

Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease.

Chrysochou C, Manzoor S, Wright J, Roberts SA, Wood G, McDowell G, Kalra PA.

Kidney Blood Press Res. 2009;32(5):373-9. doi: 10.1159/000254337. Epub 2009 Nov 3.

PMID:
19887825
17.

Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.

Eggers KM, Venge P, Lind L.

Am J Cardiol. 2013 Jan 1;111(1):131-6. doi: 10.1016/j.amjcard.2012.08.058. Epub 2012 Oct 2.

PMID:
23040598
18.

NT-proBNP: is it a more significant risk factor for mortality than troponin T in incident hemodialysis patients?

Oh HJ, Lee MJ, Lee HS, Park JT, Han SH, Yoo TH, Kim YL, Kim YS, Yang CW, Kim NH, Kang SW.

Medicine (Baltimore). 2014 Dec;93(27):e241. doi: 10.1097/MD.0000000000000241.

PMID:
25501091
19.

Amino-terminal pro-B-type natriuretic peptide as predictor of mortality in patients with symptomatic peripheral arterial disease: 5-year follow-up data from the Linz Peripheral Arterial Disease Study.

Mueller T, Dieplinger B, Poelz W, Endler G, Wagner OF, Haltmayer M.

Clin Chem. 2009 Jan;55(1):68-77. doi: 10.1373/clinchem.2008.108753. Epub 2008 Nov 6.

20.

Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients.

Shadman R, Allison MA, Criqui MH.

J Am Coll Cardiol. 2007 Jun 5;49(22):2172-81. Epub 2007 May 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk